Drug development, Tumour stroma, Cancer diagnosis, Immunoconjugates (ADCs).
An organisation focused on diagnosing and treating cancer by targeting the tumour stroma. To this end, they have developed a variety of immunoconjugates (ADCs) that target the array of cellular components that make up the peritumoural stroma and thus reduce resistance to the penetration of tumour treatments, among other things. In terms of diagnosis, the aim is to predict the invasiveness of tumours and select patients who will benefit most from immunoconjugates.
DESCRIPTION
An organisation focused on diagnosing and treating cancer by targeting the tumour stroma. To this end, they have developed a variety of immunoconjugates (ADCs) that target the array of cellular components that make up the peritumoural stroma and thus reduce resistance to the penetration of tumour treatments, among other things. In terms of diagnosis, the aim is to predict the invasiveness of tumours and select patients who will benefit most from immunoconjugates.
Keywords
Drug development, Tumour stroma, Cancer diagnosis, Immunoconjugates (ADCs).
